SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-007099
Filing Date
2022-03-17
Accepted
2022-03-17 08:30:42
Documents
74
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 782732
2 ex31-1.htm EX-31.1 19947
3 ex31-2.htm EX-31.2 20046
4 ex32-1.htm EX-32.1 6742
5 ex32-2.htm EX-32.2 6740
  Complete submission text file 0001493152-22-007099.txt   4733036

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adxs-20220131.xsd EX-101.SCH 38969
7 XBRL CALCULATION FILE adxs-20220131_cal.xml EX-101.CAL 57578
8 XBRL DEFINITION FILE adxs-20220131_def.xml EX-101.DEF 138384
9 XBRL LABEL FILE adxs-20220131_lab.xml EX-101.LAB 315099
10 XBRL PRESENTATION FILE adxs-20220131_pre.xml EX-101.PRE 254361
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 803966
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 22746866
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences